Austrália - inglês - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine, quantity: 14 g/l; arginine, quantity: 12 g/l; glycine, quantity: 11 g/l; histidine, quantity: 3 g/l; isoleucine, quantity: 5 g/l; leucine, quantity: 7.4 g/l; lysine acetate, quantity: 9.31 g/l (equivalent: lysine, qty 6.6 g/l); methionine, quantity: 4.3 g/l; phenylalanine, quantity: 5.1 g/l; proline, quantity: 11.2 g/l; serine, quantity: 6.5 g/l; taurine, quantity: 1 g/l; threonine, quantity: 4.4 g/l; tryptophan, quantity: 2 g/l; tyrosine, quantity: 400 mg/l; valine, quantity: 6.2 g/l - injection, solution - excipient ingredients: glacial acetic acid; water for injections - to supply amino acids as part of a composite admixture of total parenteral nutrition.

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

b. braun medical limited - sodium chloride; potassium chloride; sodium lactate solution; calcium chloride dihydrate - solution for infusion - per cent - solutions affecting the electrolyte balance; electrolytes

Estados Unidos - inglês - NLM (National Library of Medicine)

cardinal health 414, llc - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f-18 injection, usp, is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none any radiopharmaceutical including sodium fluoride f-18 injection, usp, has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f-18 injection, usp. prior to the administration of sodium fluoride f-18 injection, usp, to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f-18 injection, usp, should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f-18 injection, usp, is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration o

Estados Unidos - inglês - NLM (National Library of Medicine)

mayne pharma inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg - active ingredient: 0.5 mg of fluoride ion from 1.1 mg of sodium fluoride (naf). inactive ingredients: lactose, saccharine, grape flavor and magnesium stearate.

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - 6/0.27/0.4 grams - electrolytes

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - grams - electrolytes

Canadá - inglês - Health Canada

sanofi-aventis canada inc - aflibercept - solution - 100mg - aflibercept 100mg - antineoplastic agents

Estados Unidos - inglês - NLM (National Library of Medicine)

dentsply llc. professional division trading as "sultan healthcare" - fluoride ion (unii: q80vpu408o) (fluoride ion - unii:q80vpu408o) - fluoride ion 9 mg in 1 g - topex® fluoride gels are indicated for topical application to teeth to aid in the prevention of dental caries. the non-acidic nature of neutral ph (naf) is recommended for patients with ceramic or composite restorations. treatment frequency should not exceed 4 treatments per year. hypersensitivity to fluoride. do not use if patient has a known allergy to fluoride or any of the other ingredients in this product.

Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

b.braun medical industries sdn bhd - calcium gluconate for injection -

Estados Unidos - inglês - NLM (National Library of Medicine)

sofie co. dba sofie - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to defined areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluo